| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| B2XMF0 | Cytochrome c oxidase subunit 3; | COX3; | NULL | 260 | human |
| B0AZQ4 | cDNA, FLJ79494, highly similar to Structural maintenance of chromosome 3; | NULL | NULL | 1217 | human |
| I3L3W5 | Ketosamine-3-kinase; Fragment; | FN3KRP; | NULL | 102 | human |
| B2RU25 | Stromal antigen 3; | STAG3; | NULL | 1225 | human |
| I6NWH5 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| B2YGA0 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| B3CJD7 | V-myc myelocytomatosis viral oncogene homolog; Fragment; | MYC; | NULL | 252 | human |
| B3KPP7 | cDNA FLJ32033 fis, clone NTONG2000265, highly similar to Autophagy-related protein 9A; | NULL | NULL | 839 | human |
| H3BTA1 | GRAM domain-containing protein 2; Fragment; | GRAMD2; | NULL | 145 | human |
| B3KR22 | cDNA FLJ33499 fis, clone BRAMY2004351, highly similar to Noelin; | NULL | NULL | 236 | human |
| H3BNM8 | U6 snRNA phosphodiesterase; EC 3.1.4.-; | USB1; | XP_005256201.1; | 214 | human |
| G1EMU7 | MHC class I antigen; Fragment; | HLA-C; | NULL | 181 | human |
| B4DFP1 | cDNA FLJ51818, highly similar to Phosphoglucomutase-1; EC 5.4.2.2; | NULL | NULL | 538 | human |
| B4DEM0 | cDNA FLJ57951; | NULL | NULL | 137 | human |
| B4DKB3 | cDNA FLJ60625, highly similar to Ubiquitin carboxyl-terminal hydrolase isozymeL5; EC 3.4.19.12; | NULL | NULL | 108 | human |
| B2RD14 | Ubiquitin carboxyl-terminal hydrolase; EC 3.4.19.12; | NULL | NULL | 223 | human |
| B4DKX3 | cDNA FLJ51228, highly similar to Probable ATP-dependent RNA helicase DDX10; EC 3.6.1.-; | NULL | NULL | 781 | human |
| E5RGG8 | Sodium-dependent phosphate transporter 2; Fragment; | SLC20A2; | NULL | 78 | human |
| B4DK42 | cDNA FLJ61592, highly similar to Homo sapiens GTPase activating protein and VPS9 domains 1 (GAPVD1), mRNA; Fragment; | NULL | NULL | 993 | human |
| B4DEJ5 | cDNA FLJ52621, moderately similar to Homo sapiens neurochondrin (NCDN), transcript variant 3, mRNA; | NULL | NULL | 176 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |